AP2126A - Broadspectrum substituted oxindole sulfonamide HIVprotease inhibitors - Google Patents

Broadspectrum substituted oxindole sulfonamide HIVprotease inhibitors

Info

Publication number
AP2126A
AP2126A AP2005003245A AP2005003245A AP2126A AP 2126 A AP2126 A AP 2126A AP 2005003245 A AP2005003245 A AP 2005003245A AP 2005003245 A AP2005003245 A AP 2005003245A AP 2126 A AP2126 A AP 2126A
Authority
AP
ARIPO
Prior art keywords
hivprotease
sulfonamide
inhibitors
substituted oxindole
broadspectrum
Prior art date
Application number
AP2005003245A
Other languages
English (en)
Other versions
AP2005003245A0 (en
Inventor
Abdellah Tahri
Piet Tom Bert Paul Wigerinck
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of AP2005003245A0 publication Critical patent/AP2005003245A0/xx
Application granted granted Critical
Publication of AP2126A publication Critical patent/AP2126A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AP2005003245A 2002-08-14 2003-08-14 Broadspectrum substituted oxindole sulfonamide HIVprotease inhibitors AP2126A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02078384 2002-08-14
PCT/EP2003/050379 WO2004016619A1 (en) 2002-08-14 2003-08-14 Broadspectrum substituted oxindole sulfonamide hiv protease inhibitors

Publications (2)

Publication Number Publication Date
AP2005003245A0 AP2005003245A0 (en) 2005-03-31
AP2126A true AP2126A (en) 2010-06-03

Family

ID=31725465

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2005003245A AP2126A (en) 2002-08-14 2003-08-14 Broadspectrum substituted oxindole sulfonamide HIVprotease inhibitors

Country Status (18)

Country Link
US (1) US7199148B2 (ko)
EP (1) EP1546153A1 (ko)
JP (1) JP4681296B2 (ko)
KR (1) KR100994759B1 (ko)
CN (1) CN1688586B (ko)
AP (1) AP2126A (ko)
AU (1) AU2003262574B2 (ko)
BR (1) BR0305771A (ko)
CA (1) CA2493940C (ko)
EA (1) EA010486B1 (ko)
HR (1) HRP20050606B1 (ko)
IL (1) IL166462A (ko)
MX (1) MXPA05001792A (ko)
NO (1) NO331846B1 (ko)
NZ (1) NZ538714A (ko)
PL (1) PL375307A1 (ko)
WO (1) WO2004016619A1 (ko)
ZA (1) ZA200501223B (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2472580A1 (en) * 2002-01-07 2003-07-17 Sequoia Pharmaceuticals Broad spectrum inhibitors
EP1732891A4 (en) * 2004-03-11 2009-05-06 Sequoia Pharmaceuticals Inc RESISTANT PREVENTIVE INHIBITORS FOR RETROVIRAL PROTEASES
EP2422781A1 (en) * 2004-05-07 2012-02-29 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
TWI482775B (zh) 2008-09-01 2015-05-01 Tibotec Pharm Ltd 用於製備（３ｒ，３ａｓ，６ａｒ）－六氫呋喃并〔２，３－ｂ〕呋喃－３－基（１ｓ，２ｒ）－３－〔〔（４－胺基苯基）磺醯基〕（異丁基）胺基〕－１－苯甲基－２－羥基丙基胺基甲酸酯之方法
US8921415B2 (en) 2009-01-29 2014-12-30 Mapi Pharma Ltd. Polymorphs of darunavir
MX2012008627A (es) 2010-01-28 2012-09-21 Mapi Pharma Ltd Proceso para la preparacion de darunavir e intermedios de darunavir.
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
WO2012092168A1 (en) * 2010-12-27 2012-07-05 Purdue Research Foundation Fused 6,5 bicyclic ring system p2 ligands, and methods for treating hiv
WO2012092188A1 (en) * 2010-12-27 2012-07-05 Ghosh Arun K Hydrogen bond forming p1 ligands and methods for treating hiv
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
WO2016039403A1 (ja) * 2014-09-11 2016-03-17 塩野義製薬株式会社 持続性ｈｉｖプロテアーゼ阻害剤

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996022287A1 (en) * 1995-01-20 1996-07-25 G.D. Searle & Co. Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
WO1999065870A2 (en) * 1998-06-19 1999-12-23 Vertex Pharmaceuticals Incorporated Sulfonamide inhibitors of aspartyl protease
WO2001072708A2 (en) * 2000-03-24 2001-10-04 Cor Therapeutics, Inc. OXINDOLE INHIBITORS OF FACTOR Xa

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
PH30929A (en) 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
US5723490A (en) * 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
IS2334B (is) * 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
DE69415326T2 (de) 1993-08-24 1999-06-02 G.D. Searle & Co., Chicago, Ill. Hydroxyaminosulfonamide verwendbar als inhibitoren retroviraler proteasen
ATE209903T1 (de) 1993-10-01 2001-12-15 Astrazeneca Ab Verfahren i
US5756533A (en) 1995-03-10 1998-05-26 G.D. Searle & Co. Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US6150556A (en) 1995-03-10 2000-11-21 G. D. Dearle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
DK0815124T3 (da) 1995-03-10 2003-03-17 Searle & Co Heterocyckliske carbonylaminosyre-hydroxyethylamino-sulfonamidinhibitorer af retrovirale proteaser
US5705500A (en) 1995-03-10 1998-01-06 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US5753660A (en) 1995-11-15 1998-05-19 G. D. Searle & Co. Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
SI0904060T1 (en) 1996-05-20 2004-04-30 Janssen Pharmaceutic N.V. Antifungal compositions with improved bioavailability
EP0969821B1 (en) 1997-03-26 2003-06-04 Janssen Pharmaceutica N.V. Pellets having a core coated with an antifungal and a polymer
JP2001527062A (ja) 1997-12-24 2001-12-25 バーテックス ファーマシューティカルズ インコーポレイテッド アスパルチルプロテアーゼインヒビターのプロドラッグ
US6436989B1 (en) 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
WO1999033792A2 (en) 1997-12-24 1999-07-08 Vertex Pharmaceuticals Incorporated Prodrugs os aspartyl protease inhibitors
WO1999033795A1 (en) 1997-12-24 1999-07-08 Vertex Pharmaceuticals Incorporated Prodrugs of aspartyl protease inhibitors
ES2362404T5 (es) 1998-06-23 2015-11-25 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Ensayo de aptitud y métodos para reducir la resistencia del VIH a terapia
AU4828199A (en) 1998-06-23 2000-01-10 Board Of Trustees Of The University Of Illinois, The Multi-drug resistant retroviral protease inhibitors and associated methods

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996022287A1 (en) * 1995-01-20 1996-07-25 G.D. Searle & Co. Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
WO1999065870A2 (en) * 1998-06-19 1999-12-23 Vertex Pharmaceuticals Incorporated Sulfonamide inhibitors of aspartyl protease
WO2001072708A2 (en) * 2000-03-24 2001-10-04 Cor Therapeutics, Inc. OXINDOLE INHIBITORS OF FACTOR Xa

Also Published As

Publication number Publication date
CA2493940A1 (en) 2004-02-26
CA2493940C (en) 2011-11-22
HRP20050606A2 (en) 2006-02-28
AU2003262574A1 (en) 2004-03-03
AU2003262574B2 (en) 2009-07-09
PL375307A1 (en) 2005-11-28
US20060058368A1 (en) 2006-03-16
US7199148B2 (en) 2007-04-03
JP4681296B2 (ja) 2011-05-11
KR20050042141A (ko) 2005-05-04
BR0305771A (pt) 2004-10-05
JP2005537305A (ja) 2005-12-08
ZA200501223B (en) 2006-07-26
WO2004016619A1 (en) 2004-02-26
HRP20050606B1 (hr) 2014-04-25
CN1688586A (zh) 2005-10-26
NO20051291L (no) 2005-05-18
KR100994759B1 (ko) 2010-11-16
MXPA05001792A (es) 2005-04-25
NO331846B1 (no) 2012-04-23
EA200500350A1 (ru) 2005-08-25
EP1546153A1 (en) 2005-06-29
CN1688586B (zh) 2012-05-09
IL166462A (en) 2012-04-30
NZ538714A (en) 2007-03-30
AP2005003245A0 (en) 2005-03-31
EA010486B1 (ru) 2008-10-30
IL166462A0 (en) 2006-01-15

Similar Documents

Publication Publication Date Title
IL166462A0 (en) Broadspectrum substituted oxindole sulfonamide hivproteases inhibitors
IS7607A (is) Ný útskipt indól
DK1534290T3 (da) Hidtil ukendte kinasehæmmere
EG25482A (en) Inhibitors
HK1079509A1 (en) Indole or benzimidazole derivatives for modulating1 B kinase
NO20034389D0 (no) Fremgangsmåte for utledning av data
ATE517888T1 (de) Indolylmaleimid-derivate
EP1496910A4 (en) KINASE INHIBITORS
DK1501826T3 (da) Substituerede indoler som alpha-1-agonister
EP1558609A4 (en) KINASE INHIBITORS
EP1689389A4 (en) Indole compounds
IL175889A0 (en) Advanced indolinone based protein kinase inhibitors
EP1532133A4 (en) NF-: B INHIBITORS
HK1076099A1 (en) Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors
ZA200409686B (en) Bicyclic 6-aklylidene-penems as ?-lactamases inhibitors
EP1569907A4 (en) NICOTINAMIDE-BASED KINASE HEMMER
AU2003286251A1 (en) New bicyclic angiotensin ii agonists
HK1072053A1 (en) Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
AP2005003242A0 (en) Broadspectrum 2-aminobenzothiazole sulfonamide HIVprotease inhibitors.
IL164898A0 (en) Heterotricyclyl 6-alkylidene-penems as beta-lactamase inhibitors
GB0318913D0 (en) Apoptosis inhibitors
NO20022243D0 (no) Fremgangsmåte for rörlegging
DE60323130D1 (de) Indolderivaten
IL163638A0 (en) 5-Heteroaryl substituted indoles
AU2003298513A8 (en) Sterically-awkward beta-lactamase inhibitors